Correspondence 0001493152-24-031393 from AIxCrypto Holdings, Inc. (AIXC)
AIxCrypto Holdings, Inc.
Date: Aug. 12, 2024 · CIK: 0001460702 · Accession: 0001493152-24-031393
AI Filing Summary & Sentiment
File numbers found in text: 333-272623
Show Raw Text
CORRESP
1
filename1.htm
UNIVEST
SECURITIES, LLC
75
ROCKEFELLER PLAZA 18C
NEW
YORK, NY 10019
August
12, 2024
VIA
EDGAR CORRESPONDENCE
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, NE
Washington,
D.C., 20549
Re:
Qualigen
Therapeutics, Inc.
Registration
Statement on Form S-1, as amended
File
No. 333-272623
Ladies
and Gentlemen:
Reference
is made to our letter, filed as correspondence via EDGAR on August 12, 2024, in which we, as placement agent for Qualigen Therapeutics,
Inc.’s (the “Company’s”) proposed public offering, joined the Company’s request for acceleration of the
effective date of the above-referenced Registration Statement for August 12, 2024 at 4:00 p.m., Eastern Time. The Company is no longer
requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration
of the effective date.
If
you have any questions regarding the foregoing, please contact our counsel at Sullivan & Worcester LLP, Joseph Segilia, Esq. at 212-660-3027.
Very truly yours,
UNIVEST SECURITIES, LLC
By:
/s/
Bradley Richmond
Bradley
Richmond
COO
and Head of Investment Banking
cc:
Joseph
Segilia, Esq.
Sullivan
& Worcester LLP